4DMedical Ltd (AU:4DX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
4DMedical Ltd has announced a change in the director’s interest, with Dr. Robert Alan Figlin receiving 60,147 Restricted Stock Units as part of his remuneration package. These performance rights have a valuation of $36,250 and are set to vest on January 1, 2025. The issuance was approved at the company’s Annual General Meeting held on November 20, 2024.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.